Background: In the management of rheumatologic patients treated with intravenous therapies, its regular monitoring is recommended in order to ensure its safety. The Nursing Consultation for monitoring rheumatologic patients treated with Intravenous Therapies (NCIT) represents a major support to patient caring for it provides patient monitoring before treatment administration and prior to rheumatologist consultation. Objectives: To analyze number and types of incidents detected in the NCIT. Methods: A cross-sectional longitudinal, observational study of data from patients followed-up in the NCIT (which was initiated in 2012) was performed. We have collected data of gender, diagnosis, drug administered, incidents detected previously to the drug administration, and if the incident was detected by telephone (one day before drug administration) or by personal interview. Biostatistical analysis with R (3.3.2.) was performed. Results: We analyzed 7809 drug infusions corresponding to 545 patients (73% women). 48.25% of patients were diagnosed with osteoporosis (OP), 30.1% rheumatoid arthritis (RA), 5.7% ankylosing spondylitis (AS), 4.2% systemic lupus erythematous (SLE), 2.9% psoriatic arthritis (PsoA) and 8.3% had other diagnosis. The intravenous therapies were antiosteoporotic drug (7.8%) and biological and immunosuppressive treatment, being the most common drugs tocilizumab (38.89%), infliximab (31.9%) and abatacept (18.05%). In the 7809 treatment infusions, 477 incidents (4.1%) were registered, 33 of them related to the antiosteoporotic therapies and the other 444 incidents (93%) occurred in the biological therapies. The 63.7% of the incidents were detected by telephone one day before drug infusion. Statistical analysis showed that SLE patients exhibit higher tendency to incidents (4.8% of incidents in the 392 treatments for SLE patients; P=0.026) than other autoimmune diseases. On the other hand, RA and AS patients have incidents detected mainly by telephone ((P=0.047 y P=0.029 respectively). We also observed a high number of incidents in the intravenous administration of TCZ (P=0.009).
AB1081 INTEGRATING CASE FINDING AND INITIAL MANAGEMENT FOR OSTEOARTHRITIS, ANXIETY AND DEPRESSION INTO ROUTINE PRIMARY CARE NURSE-LED LONG-TERM CONDITION REVIEWS: RESULTS FROM THE ENHANCE PILOT TRIAL
Background: Co-morbid osteoarthritis (OA), anxiety and depression are undermanaged in primary care yet have significant impact on pain, disability and outcomes of other long-term conditions (LTCs). Objectives: To test the feasibility and acceptability of integrating case-finding and initial management for OA, anxiety and depression within extended primary care practice nurse (PN)-led LTC review consultations.
Methods: A stepped wedge pilot trial with process evaluation. PNs gave a study pack to patients age ≥45 years attending routine LTC reviews (asthma, COPD, hypertension, ischaemic heart disease, diabetes). The intervention included case finding questions (Generalized Anxiety Disorder (GAD2), Whooley 2-item depression, diagnosing OA clinically (hands, hips, knees or feet)) followed by further assessments (anxiety (GAD7), depression (PHQ9), joint examination). PNs completed an electronic patient record and initiated management. Predetermined success criteria were to recruit 4 practices; deliver training to 2 PNs per practice, recruit 50% of those invited, ensure 75% follow up (6 week, 6 month), and the satisfaction (GPAQ) of intervention patients to be at least as acceptable as that of control patients. 24 audio recorded consultations provided insight into fidelity of intervention delivery. Results: Four practices were recruited. PNs were sequentially trained in practice prior to switching to intervention. Of the 474 people invited, 319 responded (207 control, 112 intervention) (67%). 83% and 79% of participants returned 6 week and 6 month questionnaires respectively. Demographic characteristics, general health, pain intensity, anxiety and depression scores were similar across arms. Overall, self-reported health (EQ5D5L) was high (median 0.84; IQR 0.72, 0.94). 14% of participants reported moderate to severe depression (PHQ9). Median GPAQ scores were similar (control 1.00 (IQR: 1.00, 1.29), intervention 1.00 (IQR: 1.00, 1.14)). 96% of those in the intervention arm reported being asked about joint pain, 93% reported being asked about mood. Audio recordings revealed that case finding questions were used as intended in most consultations (joint pain 20/24 consultations, anxiety 15/24, depression 6/24). One referral to physiotherapy and none to primary care mental health services were recorded by the PNs. Conclusions: Recruitment and follow up were good. However, to target those who may benefit from the intervention, changes to the target population and eligibility criteria are required. There was reasonable delivery of the case finding questions, but limited referral and signposting, highlighting areas to optimise ahead of a main trial. Background: Axial spondyloarthritis include non-radiographic SpA (nr-SpA) and ankylosing spondylitis (AS), suggesting the extent of sacroiliac involvement on imaging techniques (1). The influence of the two conditions on patients' physical function and their impact on work capacity should be regularly assessed so that we can better contribute to patients' social integration. Objectives: The present study aims to assess the differences between AS and nr-SpA patients under anti-TNF therapy regarding disease related retirement (DR) and its contributing factors. Methods: Over a period of eleven months 136 patients diagnosed with AS or nr-SpA on current biological therapy were included. Demographic data and working status were assessed. Statistical analysis was performed with SPSS 20.0. Results: In the study cohort 69% of patients were males. The predominant age group was situated between 30 to 40 years old (29.8%), while 20.2% were over 50. Out of the study group, 66% confirm they are active in their work field with a minimum of seven hours per day, whereas 4.3% reached their retirement age. 29.8% of patients were granted a disability retirement and the majority (42.9%) belonged to the 40-50 age group. Surprisingly, 6.8% of early retired patients were under 30. Out of the DR category, 92.9% were diagnosed with AS, while the rest of 7.1% had nr-SpA. The interval from diagnosis to the initiation of biological therapy was 72.5±85.1 months for AS patients and 64.1±71.2 for nr-SpA. 23.2% of patients applied for early retirement before biological therapy and only 3.1% resumed work after anti-TNF introduction. Patient gender did not influence the working capacity. At the time of study inclusion, 12% of patients with AS and 4% of patients with nr-SpA still exhibited signs of highly active disease, according to ASDAS-CRP assessment. Conclusions: Almost a third of patients in the study group were offered early retirement due to axial SpA. The vast majority of disease related retirement patients were known with AS, thus emphasizing the extent of disability brought on by this entity. However, a significant percentage of patients suffered from nr-SpA, raising doubts as to whether clinicians can promptly diagnose this entity and offer early, appropriate treatment so that inability no longer occurs.
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